DBJG
Home
About
Services
Professionals
Insights
Contact
571-765-7700
Patent Claim to a “Therapeutically Effective” Dose Remains Valid Even If It Might Kill Patients
26
Jul, 23
|
Federal Circuit notes safety and effectiveness of patented medicines are the domain of the FDA not the USPTO
read more »
Location Where Hatch-Waxman Notice Letter Received Does Not Establish Venue
23
Nov, 21
|
The Federal Circuit addresses pleading requirements in Hatch-Waxman actions concerning venue and identification of defendants
read more »
Load More
Look Around the Archives
Search for:
Recent Posts
Continuation Patent Applications at Risk
IPR Claim Constructions Open Door to New Argument and Evidence in Reply
Patent Claim to a “Therapeutically Effective” Dose Remains Valid Even If It Might Kill Patients
Hormel Saves Its Bacon
If the IPR Doesn’t Kill the Patent, There’s Always District Court
Recent Comments
Archives
August 2023
July 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
Categories
Anticipation
Claim Construction
Damages
Declaratory Judgment
Enablement
Estoppel
Ex Parte Appeals
Expert Witness
Federal Circuit
Hatch-Waxman
Indefiniteness
Infringement
Injunction
Inter Partes Review
Inventorship
ITC
Legal Issue
Obviousness
On-sale Bar
Ownership
Patent
Patent Eligibility
Presentations
Protective Order
PTAB
Public Use
Reissue
Settlement
Standing
Terminal Disclaimer
Trademark
Transfer
Venue
Willfulness
Written Description
Patent Claim to a “Therapeutically Effective” Dose Remains Valid Even If It Might Kill Patients
26
Jul, 23
|
Federal Circuit notes safety and effectiveness of patented medicines are the domain of the FDA not the USPTO
read more »
Location Where Hatch-Waxman Notice Letter Received Does Not Establish Venue
23
Nov, 21
|
The Federal Circuit addresses pleading requirements in Hatch-Waxman actions concerning venue and identification of defendants
read more »
Load More
Look Around the Archives
Search for:
Recent Posts
Continuation Patent Applications at Risk
IPR Claim Constructions Open Door to New Argument and Evidence in Reply
Patent Claim to a “Therapeutically Effective” Dose Remains Valid Even If It Might Kill Patients
Hormel Saves Its Bacon
If the IPR Doesn’t Kill the Patent, There’s Always District Court
Recent Comments
Archives
August 2023
July 2023
May 2023
April 2023
March 2023
February 2023
January 2023
December 2022
November 2022
October 2022
August 2022
July 2022
June 2022
May 2022
April 2022
March 2022
February 2022
January 2022
December 2021
November 2021
October 2021
September 2021
Categories
Anticipation
Claim Construction
Damages
Declaratory Judgment
Enablement
Estoppel
Ex Parte Appeals
Expert Witness
Federal Circuit
Hatch-Waxman
Indefiniteness
Infringement
Injunction
Inter Partes Review
Inventorship
ITC
Legal Issue
Obviousness
On-sale Bar
Ownership
Patent
Patent Eligibility
Presentations
Protective Order
PTAB
Public Use
Reissue
Settlement
Standing
Terminal Disclaimer
Trademark
Transfer
Venue
Willfulness
Written Description
Recent Comments